{
    "nctId": "NCT02639832",
    "briefTitle": "A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.",
    "officialTitle": "N/A",
    "overallStatus": "UNKNOWN",
    "conditions": "Triple Negative Breast Cancer, Natural Killer Cells, BRCA Mutation",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 210,
    "primaryOutcomeMeasure": "Presence of cell free tumor DNA and/or circulating tumor cells from a blood sample in women with Triple Negative Breast Cancer (TNBC) or a confirmed BRCA Mutation who have completed therapy and have no evidence of active disease via LiquidBiopsy.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Signed Informed Consent Form.\n* Female.\n* Over 18 years of age.\n* Previously Treated Non-metastatic Triple Negative Breast Cancer or Women with Previously Treated Non-metastatic Breast Cancer With a confirmed BRCA Mutation who have completed therapy within three years of enrollment in this study.\n* Subject may be invited to annual review of the Subject Information and Donation Schedule by email or mail follow up for five years after sampling.\n* Subject provides written authorization for use and disclosure of protected health information (PHI).\n\nExclusion Criteria:\n\n* Any conditions inappropriate for blood drawing.\n* Known active viral or bacterial infection at time of blood draw.\n* Known HIV, Hepatitis B, or Hepatitis C infection.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}